Aethlon Medical (AEMD) Depreciation & Amortization (CF) (2010 - 2026)
Aethlon Medical (AEMD) posted Depreciation & Amortization (CF) of $79547.0 for Q1 2026, down 2.52% on a QoQ basis from $81603.0 in Q4 2025, and down 5.15% year-over-year from $83864.0 in Q1 2025.
Aethlon Medical (AEMD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Aethlon Medical's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $79547.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 5.15% year-over-year to $79547.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $323653.0 (down 4.68% YoY) and the FY2026 annual result came in at $323653.0, down 4.68% from the prior year.
- Depreciation & Amortization (CF) was $79547.0 for Q1 2026 at Aethlon Medical, down from $81603.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $91473.0 in Q4 2023 and bottomed at $25322.0 in Q1 2022.
- A 5-year average of $75793.1 and a median of $82637.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 342.06% in 2022, while the deepest fall reached 23.83% in 2022.
- Aethlon Medical's Depreciation & Amortization (CF) stood at $78126.0 in 2022, then rose by 17.08% to $91473.0 in 2023, then dropped by 8.38% to $83808.0 in 2024, then declined by 2.63% to $81603.0 in 2025, then decreased by 2.52% to $79547.0 in 2026.
- Business Quant data shows AEMD's Depreciation & Amortization (CF) at $79547.0 in Q1 2026, $81603.0 in Q4 2025, and $79866.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Aethlon Medical | 7,224.60 | 7,224.60 | - | 79,547.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,547.00 |
| Mar 31, 2026 | 79,547.00 |
| Dec 31, 2025 | 81,603.00 |
| Dec 31, 2025 | 81,603.00 |
| Sep 30, 2025 | 79,866.00 |
| Sep 30, 2025 | 79,866.00 |
| Jun 30, 2025 | 82,637.00 |
| Jun 30, 2025 | 82,637.00 |
| Mar 31, 2025 | 83,864.00 |
| Mar 31, 2025 | 83,864.00 |
| Dec 31, 2024 | 83,808.00 |
| Dec 31, 2024 | 83,808.00 |
| Sep 30, 2024 | 85,827.00 |
| Sep 30, 2024 | 85,827.00 |
| Jun 30, 2024 | 86,060.00 |
| Jun 30, 2024 | 86,060.00 |
| Mar 31, 2024 | 85,832.00 |
| Mar 31, 2024 | 85,832.00 |
| Dec 31, 2023 | 91,473.00 |
| Dec 31, 2023 | 91,473.00 |